19
Views
58
CrossRef citations to date
0
Altmetric
Original Article

Psychiatric Morbidity, Illicit Drug Use and Adherence to Zidovudine (AZT) Among Injection Drug Users with HIV Disease

, , &
Pages 475-487 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (18)

Will Small, Evan Wood, Glenn Betteridge, Julio Montaner & Thomas Kerr. (2009) The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care 21:6, pages 708-714.
Read now
NinaA. Cooperman, JeffreyT. Parsons, Brenda Chabon, KarinaM. Berg & JuliaH. Arnsten. (2007) The Development and Feasibility of an Intervention to Improve HAART Adherence Among HIV-Positive Patients Receiving Primary Care in Methadone Clinics. Journal of HIV/AIDS & Social Services 6:1-2, pages 101-120.
Read now
F. Visnegarwala, M. C. Rodriguez-Barradass, E. A. Graviss, M. Caprio, M. Nykyforchyn & L. Laufman. (2006) Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART. AIDS Care 18:4, pages 332-338.
Read now
PenelopeA. Demas, DonaldM. Thea, Jeremy Weedon, Janis McWayne, Mahrukh Bamji, Genevieve Lambert & EllieE. Schoenbaum. (2005) Adherence to Zidovudine for the Prevention of Perinatal Transmission in HIV-Infected Pregnant Women: The Impact of Social Network Factors, Side Effects, and Perceived Treatment Efficacy. Women & Health 42:1, pages 99-115.
Read now
BarryD. Adam, Winston Husbands, James Murray & John Maxwell. (2005) AIDS optimism, condom fatigue, or self‐esteem? Explaining unsafe sex among gay and bisexual men. The Journal of Sex Research 42:3, pages 238-248.
Read now
T. Kerr, A. Marshall, J. Walsh, A. Palepu, M. Tyndall, J. Montaner, R. Hogg & E. Wood. (2005) Determinants of HAART discontinuation among injection drug users. AIDS Care 17:5, pages 539-549.
Read now
A Aidala, J Havens, CA Mellins, S Dodds, K Whetten, D Martin, L Gillis & P Ko. (2004) Development and validation of the Client Diagnostic Questionnaire (CDQ): a mental health screening tool for use in HIV/AIDS service settings. Psychology, Health & Medicine 9:3, pages 362-380.
Read now
A. Loughlin, L. Metsch, L. Gardner, P. Anderson-mahoney, M. Barrigan & S. Strathdee. (2004) Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users. AIDS Care 16:4, pages 485-500.
Read now
A. J. Harzke, M. L. Williams, L. Nilsson-schönnesson, M. W. Ross, S. Timpson & K.B. Keel. (2004) Psychosocial factors associated with adherence to antiretroviral medications in a sample of HIV-positive African American drug users. AIDS Care 16:4, pages 458-470.
Read now
W. D. Klinkenberg, S. Sacks & for the Hiv/aids Treatment Adherence, Health Outcomes and Cost Study Group. (2004) Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care 16:sup1, pages 22-42.
Read now
K. K. Uldall, N. B. Palmer, K. Whetten, C. Mellins & For The Hiv/aids Treatment Adherence, Health Outcomes And Cost Study Group. (2004) Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature. AIDS Care 16:sup1, pages 71-96.
Read now
C. J. Reback, S. Larkins & S. Shoptaw. (2003) Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 15:6, pages 775-785.
Read now
Y. Mizuno, D. W. Purcell, C. Dawson-Rose, J. T. Parsons & The SUDIS team. (2003) Correlates of depressive symptoms among HIV-positive injection drug users: The role of social support. AIDS Care 15:5, pages 689-698.
Read now
Salomé N. Juethner, Warren Seyfried & Judith A. Aberg. (2003) Tolerance of Efavirenz-Induced Central Nervous System Side Effects in HIV-Infected Individuals with a History of Substance Abuse. HIV Clinical Trials 4:3, pages 145-149.
Read now
Juethner Salomé N.Seyfried Warren & Aberg Judith A.. (2003) Tolerance of Efavirenz-Induced Central Nervous System Side Effects in HIV-Infected Individuals with a History of Substance Abuse. HIV Clinical Trials 4:3, pages 145-149.
Read now
Ewald Witteveen & Erik J. C. van Ameijden. (2002) DRUG USERS AND HIV-COMBINATION THERAPY (HAART): FACTORS WHICH IMPEDE OR FACILITATE ADHERENCE. Substance Use & Misuse 37:14, pages 1905-1925.
Read now
A. R. Knowlton, C. A. Latkin, J. R. Schroeder, D. R. Hoover, M. Ensminger & D. D. Celentano. (2001) Longitudinal predictors of depressive symptoms among low income injection drug users. AIDS Care 13:5, pages 549-559.
Read now
RobertJ. Buchanan, BonnieJ. Chakravorty & ScottR. Smith. (2001) Eligibility Policies for the State AIDS Drug Assistance Programs. Social Work in Health Care 32:3, pages 81-104.
Read now

Articles from other publishers (40)

Will Small, M. J. Milloy, Ryan McNeil, Lisa Maher & Thomas Kerr. (2016) Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study. AIDS Research and Therapy 13:1.
Crossref
Michael-John S. Milloy, Brandon D.L. Marshall, Thomas Kerr, Jane Buxton, Tim Rhodes, Julio Montaner & Evan Wood. (2012) Social and structural factors associated with HIV disease progression among illicit drug users. AIDS 26:9, pages 1049-1063.
Crossref
Han-Zhu Qian, Samuel E. Stinnette, Peter F. Rebeiro, Aaron M. Kipp, Bryan E. Shepherd, Charles P. Samenow, Cathy A. Jenkins, Paul No, Catherine C. McGowan, Todd Hulgan & Timothy R. Sterling. (2011) The relationship between injection and noninjection drug use and HIV disease progression. Journal of Substance Abuse Treatment 41:1, pages 14-20.
Crossref
Diana Sylvestre. (2011) Perspective: Recognizing resistance. Nature 474:7350, pages S11-S11.
Crossref
Stephen J. Ferrando & Todd Loftus. 2008. The Spectrum of Neuro-AIDS Disorders. The Spectrum of Neuro-AIDS Disorders 393 410 .
Jori A. Berger-GreensteinCarlos A. CuevasStephen M. BradyGlenn TrezzaMark A. RichardsonTerence M. Keane. (2007) Major Depression in Patients with HIV/AIDS and Substance Abuse. AIDS Patient Care and STDs 21:12, pages 942-955.
Crossref
Diana L. Sylvestre & Barry J. Clements. (2007) Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. European Journal of Gastroenterology & Hepatology 19:9, pages 741-747.
Crossref
Marguerita Lightfoot, Mary Jane Rotheram-Borus & Heather Tevendale. (2016) An HIV-Preventive Intervention for Youth Living With HIV. Behavior Modification 31:3, pages 345-363.
Crossref
Andrea Sankar, Tracy Wunderlich, Stewart Neufeld & Mark Luborsky. (2006) Sero-positive African Americans’ Beliefs about Alcohol and Their Impact on Anti-retroviral Adherence. AIDS and Behavior 11:2, pages 195-203.
Crossref
Michelle D. FurlerThomas R. EinarsonSharon WalmsleyMargaret MillsonReina Bendayan. (2006) Longitudinal Trends in Antiretroviral Use in a Cohort of Men and Women in Ontario, Canada. AIDS Patient Care and STDs 20:4, pages 245-257.
Crossref
Patrick Peretti-Watel, Bruno Spire, France Lert & Yolande Obadia. (2006) Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug and Alcohol Dependence 82, pages S71-S79.
Crossref
Brian Wells Pence, Bradley N Gaynes, Kathryn Whetten, Joseph J Eron, Robert W Ryder & William C Miller. (2005) Validation of a Brief Screening Instrument for Substance Abuse and Mental Illness in HIV-Positive Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:4, pages 434-444.
Crossref
Joan S. Tucker, Maria Orlando, M. Audrey Burnam, Cathy D. Sherbourne, Fuan-Yue Kung & Allen L. Gifford. (2004) Psychosocial Mediators of Antiretroviral Nonadherence in HIV-Positive Adults With Substance Use and Mental Health Problems.. Health Psychology 23:4, pages 363-370.
Crossref
Claude A. Mellins, Ezer Kang, Cheng-Shiun Leu, Jennifer F. Havens & Margaret A. Chesney. (2003) Longitudinal Study of Mental Health and Psychosocial Predictors of Medical Treatment Adherence in Mothers Living with HIV Disease. AIDS Patient Care and STDs 17:8, pages 407-416.
Crossref
Joan S Tucker, M.Audrey Burnam, Cathy D Sherbourne, Fuan-Yue Kung & Allen L Gifford. (2003) Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine 114:7, pages 573-580.
Crossref
Colleen DiIorio, Ken Resnicow, Marcia McDonnell, Johanna Soet, Frances McCarty & Katherine Yeager. (2003) Using Motivational Interviewing to Promote Adherence to Antiretroviral Medications: A Pilot Study. Journal of the Association of Nurses in AIDS care 14:2, pages 52-62.
Crossref
Brian R. Edlin. (2002) Prevention and treatment of hepatitis C in injection drug users. Hepatology 36:5B, pages s210-s219.
Crossref
Brian R. Edlin. (2002) Prevention and treatment of hepatitis C in injection drug users. Hepatology 36:S1, pages S210-S219.
Crossref
Carol S. Dawson Rose & Barry Ress. (2002) HIV Transmission Risk Behaviors Among HIV-Positive Individuals: Stress and Coping in the Aftermath of 9/11. Journal of the Association of Nurses in AIDS care 13:5, pages 25-31.
Crossref
Gwen van Servellen, Betty Chang, Lorraine Garcia & Emilia Lombardi. (2002) Individual and System Level Factors Associated with Treatment Nonadherence in Human Immunodeficiency Virus-infected Men and Women. AIDS Patient Care and STDs 16:6, pages 269-281.
Crossref
Gregory M. Lucas, Kelly A. Gebo, Richard E. Chaisson & Richard D. Moore. (2002) Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 16:5, pages 767-774.
Crossref
Juan Carlos Pérez Pons, Sònia Jornet Montaña & Anna Bonet Esteve. (2002) Interacciones farmacocinéticas entre metadona y antirretrovirales en pacientes infectados por el virus de la inmunodeficiencia humana. Medicina Clínica 119:6, pages 224-229.
Crossref
Francesc Puigventós, Melcior Riera, Carla Delibes, María Peñaranda, Laura de la Fuente & Assumpció Boronat. (2002) Estudios de adherencia a los fármacos antirretrovirales. Una revisión sistemática. Medicina Clínica 119:4, pages 130-137.
Crossref
Luigi Grassi, Domenico Mondardini, Michele Pavanati, Laura Sighinolfi, Alessia Serra & Florio Ghinelli. (2001) Suicide probability and psychological morbidity secondary to HIV infection: a control study of HIV-seropositive, hepatitis C virus (HCV)-seropositive and HIV/HCV-seronegative injecting drug users. Journal of Affective Disorders 64:2-3, pages 195-202.
Crossref
Laura M. Bogart, Sheryl L. Catz, Jeffrey A. Kelly & Eric G. Benotsch. (2016) Factors Influencing Physicians’ Judgments of Adherence and Treatment Decisions for Patients with HIV Disease. Medical Decision Making 21:1, pages 28-36.
Crossref
Robert L. Cook, Susan M. Sereika, Susan C. Hunt, William C. Woodward, Judith A. Erlen & Joseph Conigliaro. (2001) Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine 16:2, pages 83-88.
Crossref
S. Kelly Avants, Arthur Margolin, Lara A. Warburton, Keith A. Hawkins & Julia Shi. (2010) Predictors of Nonadherence to HIV‐Related Medication Regimens During Methadone Stabilization. The American Journal on Addictions 10:1, pages 69-78.
Crossref
G. Pérez domínguez, M. Torrens & R. Martín-santos. (2001) Adhesión al tratamiento antirretroviral en pacientes toxicómanos con infección por el VIH. Trastornos Adictivos 3:1, pages 43-50.
Crossref
M. Barton Laws, Ira B. Wilson, Diana M. Bowser & Sarah E. Kerr. (2000) Taking antiretroviral therapy for HIV infection. Journal of General Internal Medicine 15:12, pages 848-858.
Crossref
Elisabetta Rapiti, Daniela Porta, Francesco Forastiere, Danilo Fusco & Carlo A. Perucci. (2000) Socioeconomic Status and Survival of Persons with AIDS before and after the Introduction of Highly Active Antiretroviral Therapy. Epidemiology 11:5, pages 496-501.
Crossref
Robert C. Freeman, Mark L. Williams & Lori A. Saunders. (2000) Letter to the Editor: Comparison of Antiretroviral Medication Name Recall and Antiretroviral Names on Prescription Container Labels in a Sample of Drug Users Being Treated for HIV/AIDS. AIDS Patient Care and STDs 14:8, pages 401-404.
Crossref
S. K. Schwarcz, L. C. Hsu, E. Vittinghoff & M. H. Katz. (2000) Impact of Protease Inhibitors and Other Antiretroviral Treatments on Acquired Immunodeficiency Syndrome Survival in San Francisco, California, 1987-1996. American Journal of Epidemiology 152:2, pages 178-185.
Crossref
Allen L. Gifford, Jill E. Bormann, Martha J. Shively, Brian C. Wright, Douglas D. Richman & Samuel A. Bozzette. (2000) Predictors of Self-Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens. JAIDS Journal of Acquired Immune Deficiency Syndromes 23:5, pages 386-395.
Crossref
Allen L. Gifford, Jill E. Bormann, Martha J. Shively, Brian C. Wright, Douglas D. Richman & Samuel A. Bozzette. (2000) Predictors of Self-Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens. Journal of Acquired Immune Deficiency Syndromes 23:5, pages 386-395.
Crossref
. (2001) British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy. HIV Medicine 1:2, pages 76-101.
Crossref
Marc A. SchuckitMarc A. Schuckit. 2000. Drug and Alcohol Abuse. Drug and Alcohol Abuse 291 304 .
Victoria Gordillo, Julia del Amo, Vicente Soriano & Juan González-Lahoz. (1999) Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 13:13, pages 1763-1769.
Crossref
David R. Bangsberg & Andrew Moss. (1999) When should we delay highly active antiretroviral therapy?. Journal of General Internal Medicine 14:7, pages 446-448.
Crossref
JOHN J. POTTERAT & STEPHEN Q. MUTH. (1999) Of Vice and Men: Reflections on Drug Abuse and Male Prostitution. Sexually Transmitted Diseases 26:2, pages 93-94.
Crossref
Catherine Lyons. (1997) HIV drug adherence: Special situations. Journal of the Association of Nurses in AIDS Care 8, pages 29-36.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.